Strategic Growth Drivers Shaping the Point-of-Care (POC) Coagulation Testing Devices Market Outlook 2025- 2034:Rising Prevalence of Blood Clotting Disorders Drives Growth of Point-of-Care (POC) Coagulation Testing Devices Market
Discover trends, market shifts, and competitive outlooks for the point-of-care (poc) coagulation testing devices industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
What Are the Projected Market Size and Growth Rates for the Point-of-Care (POC) Coagulation Testing Devices Market From 2025 To 2029?
There has been a significant expansion of the point-of-care (POC) coagulation testing devices market in recent years. The market size is predicted to rise from $2.12 billion in 2024 to $2.33 billion in 2025, with a compound annual growth rate (CAGR) of 9.9%. The growth recorded in the previous period can be linked to the escalating incidence of infectious and chronic diseases, a growing geriatric population, increased utilization of compact portable instruments, a surge in biomarker profiling, and rising demand for personalized healthcare.
The market size for point-of-care (POC) coagulation testing devices is predicted to experience a substantial increase in the years to come. The market is anticipated to reach $3.36 billion by 2029 with a compound annual growth rate (CAGR) of 9.7%. This growth during the predicted period is due to an increased requirement for fast and precise disease diagnosis, growing focus on wellness and preventive healthcare, increased need for rapid and on-site diagnostic tests, the surge in infectious disease outbreaks, and the emerging field of telemedicine. The key trends in this period will cover areas like integration of next-generation sequencing (NGS), the detection and analysis of RNA, single-cell PCR analysis, the use of bioinformatics software and data analysis tools, the adoption of microfluidic technologies and lab-on-a-chip systems, point-of-care testing (POCT), and the application of artificial intelligence (AI) and data analytics.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15636&type=smp
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Point-of-Care (POC) Coagulation Testing Devices Market?
The increase in blood clotting disorders is anticipated to boost the expansion of the point-of-care (POC) coagulation testing devices market. Blood clotting disorders interfere with the ability of the blood to clot effectively, with lifestyle factors such as smoking, excessive alcohol consumption, and a sedentary lifestyle playing contributory roles. These habits can negatively impact the health of blood vessels, levels of clotting factors, and blood flow, making it more likely for abnormal clot formation to occur. POC coagulation testing devices help healthcare professionals to swiftly evaluate a patient’s coagulation status, enabling speedy modifications to medication dosages and treatment strategies. For instance, the annual global survey conducted by the Canada-based international non-profit organization, the World Federation of Hemophilia, revealed that in 2022, 427,685 individuals had bleeding disorders, including 257,146 with hemophilia, and 70,034 with other bleeding disorders. Of those with hemophilia, 208,957 have Hemophilia A, 42,203 have Hemophilia B, and 5,986 have an undetermined type. Consequently, the growth of POC coagulation testing devices market is fueled by the increasing occurrence of blood clotting disorders.
Which Segments in the Point-of-Care (POC) Coagulation Testing Devices Offer the Most Growth?
The point-of-care (POC) coagulation testing devices market covered in this report is segmented –
1) By Product Type: Coagulation Monitors, Consumables, Coagulation Analyzers
2) By Technology: Optical Technology, Mechanical Technology, Electrochemical Technology
3) By Method: Prothrombin Time And International Normalized Ratio, Viscoelastic Coagulation Monitoring, Other Methods
4) By Application: Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Blood Gas And Electrolyte Testing, Other Applications
5) By End-User: Hospitals, Diagnostic Laboratories, Clinics, Other End-Users
Subsegments:
1) By Coagulation Monitors: Prothrombin Time (Pt) Monitors, International Normalized Ratio (Inr) Monitors, Activated Partial Thromboplastin Time (Aptt) Monitors, Whole Blood Coagulation Monitors, Clotting Time Monitors
2) By Consumables: Test Strips, Reagents, Control Solutions, Calibration Kits, Lancets And Needles
3) By Coagulation Analyzers: Portable Coagulation Analyzers, Benchtop Coagulation Analyzers, Fully Automated Coagulation Analyzers, Semi-Automated Coagulation Analyzers, Coagulation Testing Kits (For Home Use)
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=15636&type=smp
Which Areas Are Leading Regions in the Point-of-Care (POC) Coagulation Testing Devices Market Expansion Across the Globe?
North America was the largest region in the point-of-care (POC) coagulation testing devices market in 2024. The regions covered in the point-of-care (POC) coagulation testing devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which Technological Trends Are Reshaping the Point-of-Care (POC) Coagulation Testing Devices Industry Dynamics?
Leading businesses in the point-of-care (POC) coagulation testing apparatus sector are focusing on creating immunofluorescence-based quantitative analyzers to provide more accurate diagnoses and better management of coagulation conditions. These quantitative analyzers, backed by immunofluorescence, are laboratory tools designed to gauge and quantify certain proteins or molecules that play a part in the coagulation process, thus assisting in identifying and handling blood coagulation irregularities. In particular, the pharmaceutical company Cipla Limited, based in India, introduced Cippoint in January 2023. Utilizing immunofluorescence technology, this quantitative analyzer gives swift and precise testing results within a 3 to 15 minute time frame, helping to speed up clinical decision-making. Thanks to its user-friendly design, rapid response rate, and extensive testing features, Cippoint is a significant asset in augmenting diagnostic proficiency, supporting timely clinical conclusions, and enhancing the end results of patient care.
View the full report here:
What Are the Key Elements That Define the Point-of-Care (POC) Coagulation Testing Devices Market?
Point-of-care (POC) coagulation testing devices are portable, easy-to-use medical devices used to assess the clotting ability of blood outside of a traditional laboratory setting. They are designed to provide rapid and accurate results, allowing healthcare providers to make immediate treatment decisions for patients with coagulation disorders or those at risk of abnormal bleeding or clotting.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15636
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
